Last 7 days
-14.2%
Last 30 days
-14.8%
Last 90 days
-28.5%
Trailing 12 Months
65.3%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-18 | HENRY CHRISTIAN O | sold | -980,255 | 10.122 | -96,844 | see remarks |
2023-09-11 | HENRY CHRISTIAN O | sold | -104,520 | 10.452 | -10,000 | see remarks |
2023-08-17 | Eidel Jeff | sold | -274,844 | 10.597 | -25,936 | see remarks |
2023-08-17 | HENRY CHRISTIAN O | sold | -105,000 | 10.5 | -10,000 | see remarks |
2023-08-16 | Van Oene Mark | sold | -287,122 | 11.00 | -26,102 | see remarks |
2023-05-18 | Farmer Michele | sold | -65,027 | 12.59 | -5,165 | see remarks |
2023-05-18 | MOHR MARSHALL | acquired | 63,500 | 2.54 | 25,000 | - |
2023-03-15 | Ericson William W. | sold | -67,114 | 8.9 | -7,541 | - |
2023-03-15 | Ericson William W. | acquired | 63,500 | 2.54 | 25,000 | - |
2023-03-03 | Farmer Michele | sold | -29,931 | 9.493 | -3,153 | see remarks |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Jefferies Group LLC | reduced | -40.00 | -46,850 | 174,150 | -% |
2023-09-20 | BARCLAYS PLC | added | 100 | 2,344,000 | 4,141,000 | -% |
2023-09-12 | Farther Finance Advisors, LLC | reduced | -55.12 | -10,953 | 11,651 | -% |
2023-09-06 | Deep Track Capital, LP | reduced | -58.59 | -21,279,900 | 19,301,000 | 0.89% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 101 | 212,940 | 375,060 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -2.75 | 56,966 | 539,739 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 4.21 | 640,297 | 3,892,640 | -% |
2023-08-16 | Neo Ivy Capital Management | new | - | 802,000 | 802,000 | 0.42% |
2023-08-16 | GTS SECURITIES LLC | new | - | 2,763,730 | 2,763,730 | 0.09% |
2023-08-16 | Nuveen Asset Management, LLC | added | 0.8 | 1,201,290 | 8,818,290 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 13, 2023 | capital international investors | 2.7% | 6,099,681 | SC 13G/A | |
Feb 13, 2023 | madrone capital partners, llc | 7.3% | 16,415,933 | SC 13G/A | |
Feb 10, 2023 | nikko asset management americas, inc. | 6.26% | 14,166,193 | SC 13G/A | |
Feb 10, 2023 | ark investment management llc | 11.36% | 25,691,681 | SC 13G/A | |
Feb 10, 2023 | jackson square partners, llc | 6.64% | 15,005,177 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.97% | 20,279,035 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.2% | 18,534,459 | SC 13G/A | |
Feb 03, 2023 | sumitomo mitsui trust holdings, inc. | 6.26% | 14,166,193 | SC 13G/A | |
Jun 01, 2022 | madrone capital partners, llc | 6.0% | 13,415,933 | SC 13G | |
Feb 14, 2022 | nikko asset management americas, inc. | 5.40% | 11,915,025 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 22, 2023 | 8-K/A | Current Report | |
Sep 19, 2023 | 4 | Insider Trading | |
Sep 18, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 12, 2023 | 4 | Insider Trading | |
Aug 18, 2023 | 4 | Insider Trading | |
Aug 18, 2023 | 4 | Insider Trading | |
Aug 18, 2023 | 4 | Insider Trading | |
Aug 18, 2023 | 144/A | 144/A | |
Aug 17, 2023 | D | D | |
Aug 17, 2023 | 144 | Notice of Insider Sale Intent |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
A | 32.6B | 7.0B | -6.48% | -10.43% | 28.81 | 4.67 | 5.03% | -14.68% |
MTD | 24.1B | 4.0B | -5.58% | -3.13% | 27.06 | 6.08 | 2.30% | 16.37% |
ILMN | 20.9B | 4.5B | -19.21% | -31.55% | -5 | 4.69 | -4.92% | -21931.58% |
PKI | 16.1B | 2.8B | -15.95% | -22.45% | 19.74 | 5.69 | -24.31% | 21.35% |
WAT | 15.9B | 3.0B | -0.75% | -2.22% | 23.55 | 5.31 | 3.16% | -3.93% |
MID-CAP | ||||||||
SMALL-CAP | ||||||||
PACB | 2.2B | 146.1M | -14.78% | 65.25% | -7.02 | 15.32 | 4.72% | -55.19% |
QTRX | 939.5M | 112.0M | 0.16% | 189.80% | -14.28 | 8.39 | 0.83% | 16.42% |
ADPT | 733.4M | 189.6M | -22.00% | -26.52% | -3.84 | 3.87 | 18.74% | 17.75% |
HBIO | 174.6M | 114.1M | -3.08% | 57.31% | -32.16 | 1.53 | -5.49% | -48.58% |
CDXS | 108.9M | 99.2M | -12.85% | -74.80% | -1.92 | 1.1 | -26.56% | -199.52% |
BNGO | 97.1M | 31.5M | -3.63% | 53.68% | -0.66 | 3.08 | 35.12% | -38.47% |
CSBR | 72.8M | 52.7M | -15.89% | -34.39% | -9.64 | 1.38 | 2.10% | -1984.29% |
NSTG | 71.3M | 143.9M | -47.74% | -88.57% | -0.43 | 0.5 | 0.71% | -18.99% |
PSNL | 60.1M | 67.1M | -27.06% | -59.74% | -0.55 | 0.9 | -12.13% | -17.68% |
10.0%
-0.3%
13.2%
0.6%
100%
87.7%
69.6%
Y-axis is the maximum loss one would have experienced if Pacific Biosciences of California was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 9.0% | 146,137,000 | 134,031,000 | 128,304,000 | 136,970,000 | 139,546,000 | 134,689,000 | 130,513,000 | 121,630,000 | 105,825,000 | 92,292,000 | 78,893,000 | 79,687,000 | 82,520,000 | 90,064,000 | 90,891,000 | 82,487,000 | 78,732,000 | 75,689,000 | 78,626,000 | 84,035,000 | 89,420,000 |
Cost Of Revenue | 14.3% | 102,143,000 | 89,390,000 | 79,269,000 | 76,309,000 | 77,068,000 | 74,651,000 | 71,653,000 | 69,866,667 | 65,754,000 | 64,080,000 | 46,327,000 | - | - | - | 56,315,000 | - | - | - | - | - | - |
Gross Profit | -1.4% | 43,994,000 | 44,641,000 | 49,035,000 | 60,661,000 | 62,478,000 | 60,038,000 | 58,860,000 | 53,495,000 | 45,195,000 | 38,055,000 | 32,566,000 | 34,097,000 | 33,947,000 | 36,947,000 | 34,576,000 | 27,390,000 | 23,668,000 | 22,917,000 | 25,096,000 | 28,844,000 | 33,879,000 |
Operating Expenses | 1.2% | 370,125,000 | 365,566,000 | 356,231,000 | 345,449,000 | 347,122,000 | 314,286,000 | 269,295,000 | 223,231,000 | 164,630,000 | 143,441,000 | 136,951,000 | 132,422,000 | 136,211,000 | 140,067,000 | 135,121,000 | 140,641,000 | 133,475,000 | 130,089,000 | 126,083,000 | 119,737,000 | 121,671,000 |
S&GA Expenses | 0.8% | 162,189,000 | 160,868,000 | 160,854,000 | 153,171,000 | 147,982,000 | 137,790,000 | 124,124,000 | 104,758,000 | 87,924,000 | 73,991,000 | 72,799,000 | 71,422,000 | 76,716,000 | 80,672,000 | 75,491,000 | 79,021,000 | 72,461,000 | 68,321,000 | 63,489,000 | 57,780,000 | 58,226,000 |
R&D Expenses | -2.2% | 184,827,000 | 189,002,000 | 193,000,000 | 192,953,000 | 173,369,000 | 145,287,000 | 112,899,000 | 87,747,000 | 76,706,000 | 69,450,000 | 64,152,000 | 61,000,000 | 59,495,000 | 59,395,000 | 59,630,000 | 61,620,000 | 61,014,000 | 61,768,000 | 62,594,000 | 61,957,000 | 63,445,000 |
EBITDA | 100.0% | - | -307,903,333 | -290,078,000 | -266,535,000 | - | -252,572,000 | -255,142,000 | 8,873,000 | - | 38,407,000 | 36,885,000 | -86,672,000 | -75,310,000 | -74,666,000 | -74,308,000 | - | - | - | - | - | - |
EBITDA Margin | 100.0% | - | -2.30 | -2.26 | -1.95 | - | -1.88 | -1.95 | 0.07 | - | 0.42 | 0.47 | -1.09 | -0.91 | -0.83 | -0.82 | - | - | - | - | - | - |
Interest Expenses | -0.9% | 14,496,000 | 14,623,000 | 14,690,000 | 14,521,000 | 14,530,000 | 14,438,000 | 12,530,000 | 9,051,000 | 5,378,000 | 1,789,000 | 267,000 | 945,000 | 1,609,000 | 2,253,000 | 2,611,000 | 2,561,000 | 2,513,000 | 2,467,000 | 2,423,000 | 2,419,000 | 2,436,000 |
Earnings Before Taxes | 0.5% | -319,203,000 | -320,764,000 | -314,248,000 | -298,018,000 | -299,329,000 | -303,913,333 | -274,872,000 | -6,694,000 | - | - | 29,403,000 | -94,832,000 | - | - | -84,134,000 | - | - | - | - | - | - |
EBT Margin | 100.0% | - | -2.48 | -2.45 | -2.12 | - | -2.04 | -2.11 | -0.06 | - | 0.32 | 0.37 | -1.19 | -1.02 | -0.93 | -0.93 | - | - | - | - | - | - |
Net Income | 0.5% | -319,203,000 | -320,764,000 | -314,248,000 | -299,193,000 | -205,680,000 | -175,287,000 | -181,223,000 | -36,959,000 | -77,209,000 | -59,294,000 | 29,403,000 | -45,623,000 | -51,038,000 | -52,548,000 | -84,134,000 | -114,842,000 | -110,763,000 | -108,707,000 | -102,562,000 | -92,525,000 | -89,502,000 |
Net Income Margin | 100.0% | - | -2.39 | -2.45 | -2.18 | -1.47 | -1.30 | -1.39 | -0.30 | -0.73 | -0.64 | 0.37 | -0.57 | -0.62 | -0.58 | -0.93 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -295,706,000 | -279,961,000 | -249,041,000 | -223,574,000 | -176,273,000 | -117,111,000 | -96,891,000 | -73,460,000 | -80,287,000 | 18,464,000 | 14,473,000 | 14,728,000 | 20,664,000 | -81,148,000 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -2.6% | 1,848 | 1,896 | 1,767 | 1,819 | 1,876 | 1,937 | 2,007 | 2,034 | 1,246 | 1,253 | 414 | 300 | 214 | 235 | 148 | 146 | 171 | 186 | 170 | 183 | 137 |
Current Assets | -4.6% | 936 | 981 | 852 | 914 | 970 | 1,029 | 1,101 | 1,130 | 1,189 | 1,196 | 356 | 240 | 151 | 170 | 81.00 | 77.00 | 99.00 | 113 | 132 | 144 | 96.00 |
Cash Equivalents | -40.9% | 209 | 354 | 325 | 304 | 310 | 429 | 466 | 425 | 460 | 932 | 82.00 | 69.00 | 43.00 | 69.00 | 34.00 | 33.00 | 30.00 | 38.00 | 34.00 | 38.00 | 23.00 |
Inventory | 9.1% | 68.00 | 62.00 | 50.00 | 43.00 | 36.00 | 30.00 | 25.00 | 18.00 | 18.00 | 16.00 | 14.00 | 16.00 | 17.00 | 16.00 | 13.00 | 15.00 | 17.00 | 20.00 | 18.00 | 20.00 | 23.00 |
Net PPE | -1.3% | 40.00 | 41.00 | 42.00 | 39.00 | 38.00 | 36.00 | 33.00 | 31.00 | 25.00 | 24.00 | 25.00 | 27.00 | 28.00 | 29.00 | 30.00 | 32.00 | 33.00 | 34.00 | 34.00 | 34.00 | 36.00 |
Goodwill | 0% | 410 | 410 | 410 | 410 | 410 | 410 | 410 | 391 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | 0.1% | 1,206 | 1,204 | 1,204 | 1,192 | 1,194 | 1,202 | 1,216 | 1,193 | 988 | 972 | 78.00 | 171 | 172 | 174 | 93.00 | 95.00 | 95.00 | 91.00 | 56.00 | 51.00 | 52.00 |
Current Liabilities | 2.2% | 271 | 266 | 263 | 82.00 | 84.00 | 61.00 | 72.00 | 56.00 | 45.00 | 34.00 | 39.00 | 130 | 131 | 132 | 49.00 | 51.00 | 49.00 | 45.00 | 27.00 | 22.00 | 22.00 |
Shareholder's Equity | -7.2% | 642 | 692 | 563 | 627 | 682 | 735 | 791 | 841 | 258 | 281 | 335 | 129 | 41.00 | 60.00 | 55.00 | 51.00 | 76.00 | 95.00 | 114 | 132 | 85.00 |
Retained Earnings | -4.3% | -1,690 | -1,620 | -1,532 | -1,447 | -1,370 | -1,299 | -1,218 | -1,148 | -1,165 | -1,124 | -1,036 | -1,111 | -1,088 | -1,065 | -1,066 | -1,066 | -1,037 | -1,012 | -982 | -951 | -926 |
Additional Paid-In Capital | 0.9% | 2,335 | 2,314 | 2,100 | 2,081 | 2,058 | 2,038 | 2,010 | 1,989 | 1,423 | 1,405 | 1,372 | 1,241 | 1,129 | 1,125 | 1,121 | 1,117 | 1,113 | 1,107 | 1,096 | 1,083 | 1,012 |
Shares Outstanding | 0.3% | 250 | 250 | 227 | 226 | 224 | 222 | 221 | 202 | 199 | 195 | 192 | 167 | 154 | 153 | 153 | 153 | 153 | 151 | 150 | 149 | 132 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 6.7% | -260 | -278 | -263 | -234 | -211 | -167 | -111 | -93.73 | -70.89 | -78.96 | 20.00 | 16.00 | 16.00 | 22.00 | -78.31 | -79.12 | -76.03 | -72.97 | -66.43 | -67.64 | -71.31 |
Share Based Compensation | -1.5% | 73.00 | 74.00 | 79.00 | 80.00 | 89.00 | 86.00 | 73.00 | 60.00 | 36.00 | 24.00 | 18.00 | 16.00 | 15.00 | 16.00 | 16.00 | 20.00 | 21.00 | 22.00 | 23.00 | 21.00 | 21.00 |
Cashflow From Investing | -2593.8% | -36.83 | 1.00 | 116 | 101 | -244 | -644 | -678 | -842 | -614 | -156 | -219 | -124 | -40.93 | -30.26 | 62.00 | 60.00 | 3.00 | 7.00 | -38.41 | -22.22 | 20.00 |
Cashflow From Financing | -2.6% | 195 | 200 | 10.00 | 10.00 | 307 | 309 | 1,170 | 1,294 | 1,102 | 1,099 | 252 | 144 | 37.00 | 38.00 | 27.00 | 14.00 | 80.00 | 78.00 | 107 | 102 | 38.00 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue: | ||||
Total revenue | $ 47,573 | $ 35,467 | $ 86,473 | $ 68,640 |
Cost of Revenue: | ||||
Amortization of intangible assets | 183 | 183 | 366 | 366 |
Total cost of revenue | 32,027 | 19,274 | 61,166 | 38,292 |
Gross profit | 15,546 | 16,193 | 25,307 | 30,348 |
Operating Expense: | ||||
Research and development | 46,173 | 50,348 | 95,112 | 103,285 |
Sales, general and administrative | 40,573 | 39,252 | 80,391 | 79,056 |
Change in fair value of contingent consideration | 1,975 | (5,438) | 14,231 | (6,501) |
Total operating expense | 88,721 | 84,162 | 189,734 | 175,840 |
Operating loss | (73,175) | (67,969) | (164,427) | (145,492) |
Loss on extinguishment of debt | (2,033) | 0 | (2,033) | 0 |
Interest expense | (3,554) | (3,681) | (7,184) | (7,378) |
Other income (expense), net | 8,929 | 256 | 15,796 | (23) |
Loss before expense (benefit) from income taxes | (69,833) | (71,394) | (157,848) | (152,893) |
Expense (benefit) from income taxes | 0 | 0 | 0 | 0 |
Net loss | (69,833) | (71,394) | (157,848) | (152,893) |
Other comprehensive (loss) income: | ||||
Unrealized (loss) gain on investments | (762) | (1,372) | 2,079 | (4,370) |
Comprehensive loss | $ (70,595) | $ (72,766) | $ (155,769) | $ (157,263) |
Net loss per share: | ||||
Basic (in dollars per share) | $ (0.28) | $ (0.32) | $ (0.64) | $ (0.68) |
Diluted (in dollars per share) | $ (0.28) | $ (0.32) | $ (0.64) | $ (0.68) |
Weighted average shares outstanding used in calculating net loss per share: | ||||
Basic (in shares) | 250,070 | 224,499 | 246,074 | 223,400 |
Diluted (in shares) | 250,070 | 224,499 | 246,074 | 223,400 |
Product revenue | ||||
Revenue: | ||||
Total revenue | $ 43,655 | $ 30,175 | $ 78,309 | $ 58,419 |
Cost of Revenue: | ||||
Cost of revenue | 28,432 | 15,499 | 53,596 | 30,319 |
Service and other revenue | ||||
Revenue: | ||||
Total revenue | 3,918 | 5,292 | 8,164 | 10,221 |
Cost of Revenue: | ||||
Cost of revenue | $ 3,412 | $ 3,592 | $ 7,204 | $ 7,607 |
Condensed Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 209,287 | $ 325,089 |
Investments | 620,575 | 447,229 |
Accounts receivable, net | 24,034 | 18,786 |
Inventory, net | 67,608 | 50,381 |
Prepaid expenses and other current assets | 13,748 | 10,289 |
Short-term restricted cash | 300 | 300 |
Total current assets | 935,552 | 852,074 |
Property and equipment, net | 40,317 | 41,580 |
Operating lease right-of-use assets, net | 36,444 | 39,763 |
Long-term restricted cash | 2,422 | 2,922 |
Intangible assets, net | 409,779 | 410,245 |
Goodwill | 409,974 | 409,974 |
Other long-term assets | 13,143 | 10,528 |
Total assets | 1,847,631 | 1,767,086 |
Current liabilities | ||
Accounts payable | 16,512 | 12,028 |
Accrued expenses | 27,010 | 32,596 |
Deferred revenue, current | 24,983 | 30,498 |
Operating lease liabilities, current | 9,243 | 8,886 |
Other liabilities, current | 7,336 | 7,233 |
Contingent consideration liability, current | 186,325 | 172,094 |
Total current liabilities | 271,409 | 263,335 |
Deferred revenue, non-current | 4,992 | 1,794 |
Operating lease liabilities, non-current | 36,599 | 41,070 |
Convertible senior notes, net, non-current | 891,795 | 896,683 |
Other liabilities, non-current | 837 | 1,300 |
Total liabilities | 1,205,632 | 1,204,182 |
Commitments and contingencies | ||
Stockholders’ equity | ||
Authorized 50,000 shares; No shares issued or outstanding | 0 | 0 |
Authorized 1,000,000 shares; issued and outstanding 250,473 and 226,505 shares at June 30, 2023 and December 31, 2022, respectively | 250 | 227 |
Additional paid-in capital | 2,334,623 | 2,099,782 |
Accumulated other comprehensive loss | (2,686) | (4,765) |
Accumulated deficit | (1,690,188) | (1,532,340) |
Total stockholders’ equity | 641,999 | 562,904 |
Total liabilities and stockholders’ equity | $ 1,847,631 | $ 1,767,086 |